Subscribe
← Back to Pharma / Biotech Companies

BeiGene

百济神州

📈 688235.SH / 6160.HK / BGNE 📍 Beijing Founded 2010
Biotech, Oncology, Biologics
Global biotech company. Zanubrutinib (BTK inhibitor) approved in 70+ countries. Strong oncology pipeline with 50+ molecules.
Market Cap
$25B
Employees
10,000+
Headquarters
Beijing
Website
www.beigene.com
Stock
688235.SH / 6160.HK / BGNE
Founded
2010

Pharma / Biotech Companies

📰 Related Articles on China Industry Intel

China’s Biotech Sector Attracts Record Foreign Investment Despite Geopolitical Tensions Jun 14, 2026
US-China Biotech Decoupling Reshapes Global Drug Development Jun 19, 2026
Akeso at ASCO 2026: China Biotech’s Coming of Age as Ivonescimab Beats Keytruda Jun 17, 2026
China Pharma R&D Surge: Hengrui and Qilu Lead Innovative Drug Push Jun 16, 2026